Invesco Ltd. Magenta Therapeutics, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $10,993 - $34,908	-11,334 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $578 - $1,187	227 Added 2.04%	11,334 $33,000
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $8,226 - $15,468	-1,857 Reduced 14.32%	11,107 $49,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $12,170 - $19,829	2,005 Added 18.3%	12,964 $95,000
Q2 2021 Aug 17, 2021	BUY	$9.76 - $14.15 $106,959 - $155,069	10,959 New	10,959 $107,000
Q2 2019 Aug 14, 2019	SELL	$13.4 - $17.67 $716,203 - $944,426	-53,448 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $304,653 - $1.05 Million	53,448 New	53,448 $880,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.